Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cypros Pharmaceutical extends special exercise period of Class A warrants.


CARLSBAD Carlsbad, cities, United States
Carlsbad (kärlz`băd).

1 City (1990 pop. 63,126), San Diego co., S Calif., on the Pacific coast; settled in the 1880s, inc. 1952.
, Calif.--(BUSINESS WIRE)--Jan. 6, 1995--Cypros Pharmaceutical Corp. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:CYPR) Friday Friday: see Sabbath; week.

Friday

young Indian rescued by Crusoe and kept as servant and companion. [Br. Lit.: Robinson Crusoe]

See : Servant
 said that it has extended the special exercise period of its Class A warrants for 31 days.

In commenting on the announcement, David W. Nassif, chief financial officer of Cypros, stated: ``We have received a very positive response to the special exercise program. Since its commencement in November November: see month. , almost 60 percent of the warrants have been exercised and the company has raised almost $5 million of new capital.

``Given our spending efficiencies, this amount of new capital substantially strengthens our ability to test CPC-111 and CPC-211 in the clinic in a number of patented indications.''

The special exercise period was scheduled to end at the close of business on Jan. 9, 1995, and will now end at the close of business on Feb. 8, 1995. None of the other terms of the special program announced originally by the company on Nov. 8, 1994, were changed.

CONTACT: Cypros Pharmaceutical Corp., Carlsbad

David W. Nassif, 619/929-9500
COPYRIGHT 1995 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1995, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 6, 1995
Words:167
Previous Article:Dr. Han Young Koh joins Silicon Valley Research as director of technology.
Next Article:3DO, Matsushita enter into CD pressing agreement.
Topics:



Related Articles
Cypros Pharmaceutical initiates special exercise program for Class A warrants.
Cypros Pharmaceutical extends special exercise period of Class A warrants.
Cypros Pharmaceutical raises $9.8 million in special warrant exercise program.
Cypros Pharmaceutical Corp. responds to decline in common-stock price.
Cypros Pharmaceutical Corp. announces listing of common stock and Class B warrants on NASDAQ National Market System.
Cypros Pharmaceutical Corp. announces a 2.5:1 stock split.
Cypros Pharmaceutical repurchases common stock.
Cypros Pharmaceutical closes $7 million Regulation D private placement of convertible notes.
HELIX BIOPHARMA CORP. FILES FINAL PROSPECTUS IN CONNECTION WITH $5 MLLLION SPECIAL WARRANT PLACEMENT COMPLETED IN JUNE 1996.
Cypros Pharmaceutical Raises $4.7 Million Through Partial Exercise Of Class B Warrants; Remainder Of Warrants Expire.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles